Chemclin Diagnostics Co. Ltd. A (688468) — Capital Reinvestment Ratio
Chemclin Diagnostics Co. Ltd. A (688468) has a Capital Reinvestment Ratio of 0.27x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥34.41 Million) in capital expenditures (CN¥9.16 Million). See Chemclin Diagnostics Co. Ltd. A balance sheet quality to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Chemclin Diagnostics Co. Ltd. A Capital Reinvestment Ratio (2017–2025)
This chart tracks Chemclin Diagnostics Co. Ltd. A's Capital Reinvestment Ratio across 9 annual periods. Check 688468 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Chemclin Diagnostics Co. Ltd. A (2017–2025)
Year-by-year Capital Reinvestment Ratio for Chemclin Diagnostics Co. Ltd. A from 2017 to 2025. For live market cap and broader valuation context, see Chemclin Diagnostics Co. Ltd. A (688468) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.74x | CN¥93.90 Million | CN¥69.88 Million | ▲ +16.3% |
| 2024 | 0.64x | CN¥167.95 Million | CN¥107.49 Million | ▼ -63.2% |
| 2023 | 1.74x | CN¥173.05 Million | CN¥301.37 Million | ▲ +240.0% |
| 2022 | 0.51x | CN¥244.56 Million | CN¥125.28 Million | ▲ +33.4% |
| 2021 | 0.38x | CN¥188.86 Million | CN¥72.55 Million | ▼ -29.9% |
| 2020 | 0.55x | CN¥151.95 Million | CN¥83.31 Million | ▲ +99.8% |
| 2019 | 0.27x | CN¥201.27 Million | CN¥55.24 Million | ▼ -16.4% |
| 2018 | 0.33x | CN¥147.68 Million | CN¥48.51 Million | ▼ -26.2% |
| 2017 | 0.45x | CN¥133.46 Million | CN¥59.43 Million | — |